WO2001056503A1 - Endoluminal prostheses having radiopaque marker - Google Patents

Endoluminal prostheses having radiopaque marker Download PDF

Info

Publication number
WO2001056503A1
WO2001056503A1 PCT/US2001/003407 US0103407W WO0156503A1 WO 2001056503 A1 WO2001056503 A1 WO 2001056503A1 US 0103407 W US0103407 W US 0103407W WO 0156503 A1 WO0156503 A1 WO 0156503A1
Authority
WO
WIPO (PCT)
Prior art keywords
prosthesis
liner
plate
imagable
shanks
Prior art date
Application number
PCT/US2001/003407
Other languages
French (fr)
Inventor
Darin C. Gittings
Denise M. Demarais
Original Assignee
Medtronic Ave Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Ave Inc. filed Critical Medtronic Ave Inc.
Publication of WO2001056503A1 publication Critical patent/WO2001056503A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18Materials at least partially X-ray or laser opaque
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Definitions

  • the present invention relates generally to tubular prostheses, such as grafts, stents, stent- grafts, and the like. More particularly, the present invention provides endoluminal prostheses having improved position indicating.elements which facilitate orienting and deploying of the prostheses within body lumens, particularly within branching blood vessels for the treatment of abdominal and other aneurysms.
  • Vascular aneurysms are the result of abnormal dilation of a blood vessel, usually resulting from disease and/or genetic predisposition, which can weaken the arterial wall and allow it to expand. While aneurysms can occur in any blood vessel, most occur in the aorta and peripheral arteries, with the majority of aortic aneurysms occurring in the abdominal aorta, usually beginning below the renal arteries and often extending into one or both of the iliac arteries.
  • Aortic aneurysms are most commonly treated in open surgical procedures, where the diseased vessel segment is bypassed and repaired with an artificial vascular graft. While considered to be an effective surgical technique, particularly considering the alternative of a usually fatal ruptured abdominal aortic aneurysm, conventional vascular graft surgery suffers from a number of disadvantages. The surgical procedure is complex and requires experienced surgeons and well equipped surgical facilities. Even with the best surgeons and equipment, however, patients being treated frequently are elderly and weakened from cardiovascular and other diseases, reducing the number of eligible patients. Even for eligible patients prior to rupture, conventional aneurysm repair has a relatively high mortality rate. Morbidity related to the conventional surgery includes myocardial infarction, renal failure, impotence, paralysis, and other conditions.
  • endoluminal prostheses are critical to the efficacy of endovascular aneurysm therapies.
  • These tubular prostheses are generally introduced into the vascular system within a catheter and in a radially compressed configuration, typically being maneuvered into position under fluoroscopy.
  • the positioned prosthesis will radially expand, preferably engaging and sealing against the endolithium of the healthy vessel wall both upstream and downstream of the weakened, distended aneurysm.
  • the prosthesis may expand resiliently when released from the catheter, or may be mechanically expanded, typically using a balloon catheter.
  • the prosthesis will preferably span the entire aneurysm to prevent pressure from acting on the weakened luminal wall, and to prevent leakage through any rupture of the aneurysm.
  • the prosthesis should be axially positioned accurately across the aneurysm so as to isolate the aneurysm from the blood flow through the prosthetic lumen.
  • Proper radial orientation of endoluminal prostheses is also important, particularly when deploying branching and asymmetric prostheses within the tortuous vascular system. If the branches of branching prostheses are not oriented toward their respective branching body lumens, the surrounding body lumen may be distended to adapt to the misaligned prosthesis, or the prosthetic lumen may be distorted or even closed entirely. For example, if the trunk of a bifurcated prosthesis is deployed with a branch oriented 90° from the iliac arteries (i.e., angling dorsally rather than laterally), the prosthetic branch lumen may fold or kink, and will have to at least bend at a sharp angle to enter the laterally oriented iliac.
  • branching prostheses are often assembled in situ, it may not be possible to introduce the branch prosthesis into such a misaligned branch port.
  • recapture or repositioning of expanded endoluminal prostheses is often problematic, it may even be necessary to resort to an emergency invasive procedure to remedy such misalignment.
  • Tubular endovascular prostheses are often formed as stent-grafts having a flexible tubular liner or "graft" which is supported by a perforate tubular frame or "stent".
  • the frame perforations define radially expandable structures, while the frame often include metals which are, to some extent, visible under fluoroscopy.
  • a tube be crimped over an element of the frame. Unfortunately, affixing such structures to the frame may limit or interfere with the radial compressibility of the prosthesis.
  • radiopaque lines or image markers to bifurcated grafts in the form of fine wire or chain, either woven into the cloth or applied after weaving, or as an inert paint or plastic.
  • the liners of endoluminal prostheses should remain highly flexible, typically being folded when the prosthesis is compressed and unfolding during deployment. Wires, chains, or paints which are sufficiently flexible will generally provide only limited-contrast images when the graft is supported by the obscuring frame, and may become detached from the prosthesis once deployed in the body lumen.
  • imaging of such thin, flexible, low-contrast markers is particularly difficult when the prosthesis is in the high density, radially compressed configuration and disposed within a catheter, as is generally required for intravascular maneuvering.
  • endoluminal prostheses and methods for their use It would be particularly desirable to provide endoluminal prostheses having high-contrast orientation indicating imaging markers which do not interfere with radial compression or expansion, and which are securely and reliably attached to the prosthesis without using sutures, adhesives, and/or weaves. It would further be desirable if such markers could clearly indicate both the position and orientation of the prosthesis, ideally while the prosthesis remains compressed in the delivery catheter, but without substantially increasing the size of the delivery system and/or incurring the high costs of known marker attachment techniques.
  • the present invention provides improved endoluminal prostheses (and methods for their use) having discrete position indicating elements which facilitate the o ⁇ enting and deploying of the prostheses within body lumens. More specifically the endoluminal prostheses includes endovascular prostheses, often formed as stent-grafts having an improved radiopaque image marker to be applied to the graft before the graft is deployed.
  • the marker is in the form of a flat metal plate resembling a circular d i sk or "button," however, the shape of the plate may be modified as desired to conform to the needs of the application.
  • the plate may be fastened or secured on to the graft at any desired position using a pair of fastening shanks or tangs which extend parallel to each other outward from a major surface of the plate, in a fashion similar to the fastening shanks of a common staple.
  • the marker herein referred to as a "staplebutton” marker is operated by forcing the fastening shanks through the graft liner, until an underside of the button rests on the liner. Each shank is then folded down on the other side of the liner, so as to bind the material between the folded fastening shanks and the button.
  • the staplebutton thus described provides a high-contrast, orientation indicating imaging marker, which does not interfere with radial compression or expansion of an endoluminal prostheses on which it is being used.
  • the staplebutton can be securely and reliably attached to the liner or any other portion of the prosthesis without fear of the inadvertent detachment of the marker
  • One other advantage of the liner supported marker element is that the marker element can move out of the way of the frame with the liner when the prosthesis is compressed and further, it remains out of the way when the liner (and frame) is deployed.
  • the staplebutton marker can also clearly indicate both the position and orientation of the prosthesis, while the prosthesis remains compressed in the delivery catheter, but without substantially increasing the size of the delivery system.
  • the present invention provides a tubular graft comprising a polyester fabric and an imagable body disposed on the liner.
  • the body includes a plate and at least two shanks integral with the plate, the shanks affixing the imagable body on the liner.
  • the imagable body provides a sharp contrast so as to indicate the liner position when the prosthesis is imaged within the patient body.
  • the present invention provides an endoluminal prosthesis for deployment in a body lumen of a patient body.
  • the prosthesis includes a tubular fabric liner having a proximal end, a distal end, and a lumen therebetween.
  • a plurality of imagable bodies are attached to the liner and provide a sharp contrast so as to define a pattern which indicates the prosthesis position when the prosthesis is imaged within the patient body.
  • Each imagable body has a plate and two integral fastening members, which facilitate the attachment of the imagable bodies to the liner.
  • the present invention provides an endoluminal prosthesis for deployment in a body lumen of a patient body.
  • the prosthesis includes a tubular fabric liner having a proximal end, a distal end, and a lumen therebetween and a radially expandable frame which supports the liner.
  • a plurality of radiopaque marker elements are disposed on the liner.
  • Each marker includes a plate having a first and a second opposed major surface and two fastening members which extend from the second major surface, through the line, and along the plate so that the marker elements are attached to the hner.
  • the marker elements indicate a position of the prosthesis when the prosthesis is imaged within the body lumen.
  • the imagable bodies described above can be aligned with openings of a perforate frame structure used to support the fabric liner so that at least some of the imagable bodies are visible through the associated openings when the frame is expanded.
  • the markers need not actually be attached to the frame directly.
  • Such imagable bodies are clearly visible when the prosthesis is deployed and can also be sized to produce distinct images even when the frame is compressed within a delivery catheter, but should not interfere with the radial expansion of the frame during deployment.
  • the imagable bodies optionally comprise a radiopaque material, or may alternatively produce enhanced ultrasound images.
  • FIG. 1 A is a cross-sectional side view of an artery having an exemplary liner having axially constant characteristics.
  • Fig. IB is a side view of an exemplary cylindrical vascular stent-graft having axially constant characteristics.
  • Fig. 2 is a perspective view of an exemplary delivery catheter for use with the prostheses of the present invention, with a portion of the distal end broken away to disclose a prostheses therein.
  • Fig. 3 illustrates a modular branching endoluminal prosthesis assembled from expansible prosthetic modules.
  • Figs. 4-5B illustrate orientation indicating stent-grafts having a liner that supports marker elements, the marker elements comprising imagable bodies which define a pattern that facilitates orienting and assembling the prostheses in situ when the prosthesis is imaged fluoroscopically within a body lumen.
  • Figs. 6-6B illustrate a preferred radiopaque marker element comprising an imagable body in the form of a plate having fastening shanks to facilitate attachment of the plate to the liner.
  • Figs- 7 A and 7B illustrate a method for installing the radiopaque marker elements to the liner of an endoluminal prosthesis.
  • the present invention provides radially expansible tubular prostheses, particularly grafts, which generally include discrete, marker elements that provide a high- contrast image when viewed under fluoroscopy, ultrasound, or some other surgical imaging modality, so as to facilitate the proper positioning of the prosthesis within a body lumen.
  • the prostheses of the present invention are suitable for a wide variety of therapeutic uses, including grafting portions of the ureter, urethra, trachea, branchi, esophagus, biliary tract, and the like.
  • the present devices and methods will also be useful for the creating of temporary or long term lumens, such as the formation of fistulas.
  • the prosthetic structures of the present invention will find their most immediate use as endovascular prostheses for the treatment of diseases of the vasculature, particularly aneurysms, stenoses, and the like, and are especially well suited for therapies to treat abdominal aortic aneurysms adjacent the aortal/iliac junction.
  • These prostheses will generally be radially expansible from a narrow diameter configuration to facilitate introduction into the body lumen, typically during surgical cutdown or percutaneous introduction procedures.
  • prosthetic structures described hereinbelow will find use in axially uniform cylindrical prostheses, in preassembled bifurcated prostheses, and as prosthetic modules which are suitable for selective assembly either prior to deployment, or in situ.
  • Such selective assembly of prosthetic modules to form a customized endoluminal prosthesis is more fully described in co-pending U.S. Patent Application Serial No. 08/704,960 and U.S. Patent No. 5,824,037 the full disclosures of which are herein incorporated by reference.
  • FIG. 1A An exemplary cylindrical graft structure is shown in Fig. 1A. Artery A j is shown with its lumen forced open by a form of a tubular graft liner 18, having a proximal end, a distal end, and a graft lumen therebetween.
  • Fig. IB Another exemplary cylindrical graft structure 10 is illustrated in Fig. IB.
  • Prostheses 10 comprises a perforate tubular frame 12 which includes a plurality of independent (non-connected) ring frames 14.
  • the tubular frame 12 supports an inner liner 18.
  • an outer liner is disposed over the ring frames, either inside of inner liner 18, or in combination therewith.
  • the liner is typically sutured to the frame.
  • a wide variety of alternative liner/frame attachment mechanisms are available, including adhesive bonding, heat welding, ultrasonic welding, and the like.
  • the ring frames may be sandwiched between the liners and held in place by attaching the liners to each other.
  • the prostheses 10 will typically have a length in the range from about 20 mm to 500 mm, preferably from 50 mm to 200 mm, with a relaxed diameter in the range from about 4 mm to 45 mm, preferably being in the range from about 5 mm to 38 mm. Referring now to Fig.
  • an exemplary delivery catheter 30 for use with the endoluminal prostheses of the present invention comprises a tubular cover 32 and a shaft 34.
  • Cover 32 has a central lumen 36 extending from a proximal end 38 to a distal end 40.
  • Shaft 34 is slidably received within central lumen 36 and extends proximally of cover 32.
  • a plurality of runners 42 extend distally from shaft 34. Runners 42 line a portion of the inner surface of lumen 36, and slide within the lumen of the shaft.
  • Shaft 34 also has a lumen, in which a core shaft 44 is slidably disposed.
  • Core shaft 44 has a guide wire lumen 46.
  • Nosecone 48 is fixed to the distal end of core shaft 44, and can therefore be manipulated independently of runners 42.
  • Prostheses 10 is radiajly compressed and restrained within the plurality of runners 42.
  • cover 32 prevents runners 42 from expanding outward.
  • Runners 42 are formed from a hard material, and distribute the expansion load of prostheses 10 over the inner surface of central lumen 36. The deploying force is applied proximally against a slider 50 attached to a distal end 38 of cover 30, while holding a luer fitting 52 at the distal end of shaft 34, thereby withdrawing the cover proximally from over the prostheses.
  • An additional luer adapter 54 at the distal end of core shaft 44 allows the core shaft to be manipulated independently, and to be releasably secured to the shaft 34.
  • Exemplary methods and devices for placement of the prostheses of the present invention are more fully described in Application Serial Nos. 08/862,085, filed May 22, 1997 (Attorney Docket 16380-001 160) and 09/127,666, filed July 31, 1998 (Attorney Docket 16380-001170) and U.S. Patent Nos. 5,683,451 and 5,824,041, the full disclosures of which are incorporated herein by reference.
  • a branching endoluminal stent-graft 60 is assembled from prosthetic modules selected to match the needs of the diseased vascular system of the patient.
  • a common lumen cuffed prosthetic module 62 seals and anchors the assembled prosthesis in the body lumen, typically within the abdominal aorta below the renal arteries and above the left and right iliac arteries.
  • Y-connector module 64 engages cuffed common lumen module 62, and separates the blood flow for the iliac arteries.
  • First angled branching prosthetic module 66 and second angled branching prosthetic module 68 engage the branch lumens of Y- connector module 64 to direct the luminal flow along first and second branching body lumens.
  • an orientation indicating bifurcated prosthesis 80 includes a plurality of discrete marker elements 82 which form an orientation indicating pattem 84 when imaged using fluoroscopy, ultrasound, or other imaging modalities.
  • Such bifurcated prostheses will be particularly useful for reinforcing abdominal aortic aneurysms which extend into one or both iliac arteries, and are typically to be used in combination with a secondary prosthetic module engaging port 85 to seal the port to the body lumen system.
  • pattem 86 Toward that end, pattem 86 preferably indicates the axial location of the ends, and the axial and radial orientation of port 85, when the prosthesis is in a radially compressed configuration within a delivery catheter, and after deployment to assist deploying the secondary prosthesis within port 85.
  • Minimizing the radial dimensions of the prosthesis significantly facilitates the intravascular maneuvering of the prosthesis during positioning and deployment. Therefore, it is generally desirable that marker elements 82 have the least possible volume to avoid increases in the delivery catheter cross-section.
  • marker elements should not interfere with the radial expansion of the prosthesis from the radially compressed configuration to the radially expanded configuration, during which perforations 86 of frame 88 expand substantially.
  • the pattern should provide a sharp image, despite the fact that frame 88 will often at least partially obscure the pattern when the prosthesis is imaged.
  • marker elements 82 are preferably aligned with perforations 86, ideally being substantially disposed within the perforations to maximize their image contrast against the generally radiographically clear liner 90.
  • supporting the marker elements with the liner rather than attaching them directly to the frame, also helps avoid interference between the marker elements and the expansion of the surrounding frame structure. Additionally, supporting the marker elements on the liner so that they are separated from the frame will help to avoid erosion of the frame as the marker elements will not rub against the frame with physiological movement.
  • Pattern 84 defined by marker elements 82 includes several novel features.
  • a port orientation indicator 92 is preferably disposed adjacent an end of the prosthesis which will be expanded before the port, and helps to verify that the orientation of port 85 will be aligned properly with the intended branching body lumen before the port is expanded in position. Fine rotational alignment of the prosthesis is facilitated by including roughly opposed marker elements 94, so that the preferred radial orientation of the prosthesis can be provided by orienting the imaging mechanism relative to the body lumen system.
  • a still further feature of pattern 84 is the two axially separated gates 96 adjacent port 85.
  • the axial positions and separation of these gates gives a visual indicator of the allowable prosthetic module overlap when the prosthesis is deployed and imaged in situ. Modular prostheses having less than a predetermined overlap may not be adequately fixed together, while branches which extend too far into the bifurcated prosthesis may lead to an imbalance in the flow between the branches, or may even fold over and substantially block the luminal flow to one or both branches.
  • an overlap is acceptable when an end (or an associated overlap marker) of a secondary prosthesis is disposed between the gates.
  • the gates are defined by markers on either side of the port centerline, greatly improving the visibility of the markers when the delivery catheter of a secondary prosthesis enters the port.
  • a pattern including such gates provides a clear demarcation of the target path between the markers when advancing a guidewire and/or a delivery catheter into the port 85 of bifurcated prosthesis 80.
  • branch secondary prosthetic module 100 and trunk secondary prosthetic module 102 also include image markers 82 which define patterns to facilitate axially positioning and radially orienting these modules within a body lumen, particularly with reference to bifurcated prosthesis 80 described above.
  • Each of branch module 100 and trunk module 102 include marker elements 106 which produce an image which is aligned along a prosthetic centerline 104 when the prosthesis is properly positioned relative to the imaging apparatus.
  • marker elements 106 may be aligned with a guidewire passing through the prosthetic lumen even if no other rotational alignment marker is provided, thereby minimizing the total number of markers.
  • Asymmetric marker elements 108 are radially offset from the centerline markers, preferably defining a radial angle between about 15° and 70° with centerline markers 106, to ensure that the modules are not 180° out of rotational alignment, which could be problematic if the modules have a preferred bend angle or some other asymmetric structure.
  • a roughly 30° radial angle is preferred, as flat thin marker elements will produce smaller images when viewed edge-on that tend to blend into the frame as the angle approaches 90°, while smaller angles will be difficult to differentiate.
  • significantly off-centerline markers are less likely to be overshadowed by subsequent guidewire or delivery catheter placements.
  • Left and right off-centerline markers may be included to ensure the prosthesis is not roughly 150° out of rotational alignment.
  • the * asymmetric marker elements can also easily be aligned with the port indicator markers 92 or otherwise consistently aligned with some other imagable structure of the bifurcated prosthesis of Fig. 5A.
  • the prostheses of the present invention will often include different materials for the frame and for the marker elements.
  • the frame material will often comprise a high strength metal
  • the marker elements will generally comprise a radiopaque metal or a metal which produces an enhanced ultrasound image.
  • EMF Electromotive Force
  • the present invention provides endoluminal prostheses with frames and marker element having similar EMF characteristics.
  • a particularly preferred combination combines frames which include Nitinol® and marker elements which include tantalum. These materials exhibit excellent strength and imagability, respectively, and are of sufficiently similar characteristics to avoid electrolytic corrosion.
  • the imagable body here comprises a plate 130 attached to liner 132.
  • Plate 130 includes two opposed major surfaces 131 and 133 and at least two fastening members or shanks 134 and 136 to facilitate the attachment.
  • Plate 130 and shanks 134 and 136 generally comprise a material which provides a high sharp contrast when imaged, so as to indicate the liner position when the prosthesis is imaged within the patient body.
  • Plate 130 typically includes a radiopaque material such as gold, platinum, or other implantable metals.
  • plate 130 comprises tantalum having a thickness of at least about .002 inches, preferably being about .01 inches.
  • Such tantalum plates may be mass produced by die cutting or laser cutting sheet stock. In most embodiments, the edges of plates 130 will be rounded to avoid any injury to adjacent tissues, and to avoid cutting any liner or attachment fibers.
  • the plates are often attached to the outer surface of the liner material to avoid interference with the vascular flow or the generation of thrombus.
  • the prosthetic lumen remains uninterrupted.
  • the plates are generally attached along a radius of the liner, they should not substantially interfere with expansion of the liner material.
  • Plate 130 may include a variety of alternative shapes.
  • plate 130 could be shaped as, but is not limited to, a square, a triangle, an oval, an arrow, a number or a letter. Each shape may correspond to a different application or need.
  • a port orientation indicator 92 could be shaped as a circular disk, while gates 96 may be shaped as ovals. Still other marker elements 82 may have plates shaped as arrows to indicate deployment and/or blood flow direction. Regardless of the shape of plate 130, the imagable bodies should be securely and reliably fastened to liner 132.
  • the imagable bodies includes at least two shanks 134 and 136.
  • shanks 134 and 136 are made integral with plate 130.
  • the shanks may be separately formed and attached to plate 130 using conventional adhesives techniques such as welding and the like.
  • the shanks 134 and 136 provide the primary means for affixing the imagable body to liner 130.
  • the shanks can be used to affix marker 82 to external frame 140 within the scope of the present invention.
  • each shank 134 and 136 projects outward from plate 130.
  • Shanks 134 and 136 are bent over, in the same direction, at right-angles to plate 130.
  • the cantilevered end of the shanks 135 and 137 each end at a point sufficiently sharp enough to pierce fabric liner 132 without collapsing the shank upon the application of pressure to the marker.
  • each shank 134 and 136 is cut at right and left opposing angles 139 and 141 so that the shanks lay side-by-side, substantially in the same plane, when the shanks are bent over parallel to the plate.
  • installation tool 200 is generally formed of two opposed clamping members 202 and 204.
  • One clamping member has a recessed portion 206 capable of receiving major surface 131 of plate 130.
  • the second clamping member 204 has a recessed portion 210 that is designed ⁇ yith a surface feature capable of receiving shanks 134 and 136.
  • marker 82 - is positioned over a predetermined location on liner 132.
  • Shanks 134 and 136. * are forced to pierce liner 132 and pushed through until major surface 133 is disposed proximate to the liner.
  • the clamping members 202 and 204 are then placed over marker 82 and plate 130 is inserted into recessed portion 206.
  • a clamping force is then brought to bear on plate 130 and shanks 134 and 136 in the directions of arrows 208.
  • the surface features of recessed portion 210 are designed to bend shanks 134 and 136 in a direction towards the center of plate 130 until desired or until the shanks are generally parallel to plate 130.
  • liner 132 is bound between the bent over shanks and major surface 133.
  • the clamping tool nothing else is needed to secure marker 82 to liner 132. Therefore, adhesives, sutures, or other attachment means are not necessary.

Abstract

Improved endoluminal prostheses and methods for their use, having discrete position indicating elements which facilitate the orienting and deploying of the prostheses within body lumens. The endoluminal prostheses may include endovascular prostheses, often formed as stent-grafts having a flexible tubular liner or 'graft'. The position indicating elements may include an improved radiopaque image marker to be applied to the graft, before the graft is deployed particularly within branching blood vessels for the treatment of abdominal and other aneurysms. The marker is in the form of a flat metal blank resembling a circular plate or 'button'. The disk may be fastened or secured onto the graft using a pair of fastening shanks or tangs which extend parallel to each other outward from a surface of the plate.

Description

ENDOLUMINAL PROSTHESIS HAVING RADIOPAQUE MARKER
CROSS REFERENCE TO RELATED APPLICATION
This application is based on the following U.S. Provisional Application: Serial number 60/118,576, filed on February 5, 1999, entitled STAPLEBUTTON RADIOPAQUE MARKER, naming Darin C. Gittings and Denise M. DeMarais as inventors.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to tubular prostheses, such as grafts, stents, stent- grafts, and the like. More particularly, the present invention provides endoluminal prostheses having improved position indicating.elements which facilitate orienting and deploying of the prostheses within body lumens, particularly within branching blood vessels for the treatment of abdominal and other aneurysms.
Vascular aneurysms are the result of abnormal dilation of a blood vessel, usually resulting from disease and/or genetic predisposition, which can weaken the arterial wall and allow it to expand. While aneurysms can occur in any blood vessel, most occur in the aorta and peripheral arteries, with the majority of aortic aneurysms occurring in the abdominal aorta, usually beginning below the renal arteries and often extending into one or both of the iliac arteries.
Aortic aneurysms are most commonly treated in open surgical procedures, where the diseased vessel segment is bypassed and repaired with an artificial vascular graft. While considered to be an effective surgical technique, particularly considering the alternative of a usually fatal ruptured abdominal aortic aneurysm, conventional vascular graft surgery suffers from a number of disadvantages. The surgical procedure is complex and requires experienced surgeons and well equipped surgical facilities. Even with the best surgeons and equipment, however, patients being treated frequently are elderly and weakened from cardiovascular and other diseases, reducing the number of eligible patients. Even for eligible patients prior to rupture, conventional aneurysm repair has a relatively high mortality rate. Morbidity related to the conventional surgery includes myocardial infarction, renal failure, impotence, paralysis, and other conditions. Additionally, even with successful surgery, recovery takes several weeks, and often requires a lengthy hospital stay. 2 In order to overcome some or all of these drawbacks, endova≤cular prosthesis placement for the treatment of aneurysms has been proposed. Although very promising, many of the proposed methods and apparatus suffer from undesirable limitations. In particular, proper positioning of an endovascular prosthesis within the vascular system can be problematic.
Accurately positioning and orienting endoluminal prostheses is critical to the efficacy of endovascular aneurysm therapies. These tubular prostheses are generally introduced into the vascular system within a catheter and in a radially compressed configuration, typically being maneuvered into position under fluoroscopy. The positioned prosthesis will radially expand, preferably engaging and sealing against the endolithium of the healthy vessel wall both upstream and downstream of the weakened, distended aneurysm. The prosthesis may expand resiliently when released from the catheter, or may be mechanically expanded, typically using a balloon catheter. In either case, the prosthesis will preferably span the entire aneurysm to prevent pressure from acting on the weakened luminal wall, and to prevent leakage through any rupture of the aneurysm. To provide these advantages, the prosthesis should be axially positioned accurately across the aneurysm so as to isolate the aneurysm from the blood flow through the prosthetic lumen.
Proper radial orientation of endoluminal prostheses is also important, particularly when deploying branching and asymmetric prostheses within the tortuous vascular system. If the branches of branching prostheses are not oriented toward their respective branching body lumens, the surrounding body lumen may be distended to adapt to the misaligned prosthesis, or the prosthetic lumen may be distorted or even closed entirely. For example, if the trunk of a bifurcated prosthesis is deployed with a branch oriented 90° from the iliac arteries (i.e., angling dorsally rather than laterally), the prosthetic branch lumen may fold or kink, and will have to at least bend at a sharp angle to enter the laterally oriented iliac. In fact, as branching prostheses are often assembled in situ, it may not be possible to introduce the branch prosthesis into such a misaligned branch port. As recapture or repositioning of expanded endoluminal prostheses is often problematic, it may even be necessary to resort to an emergency invasive procedure to remedy such misalignment.
Tubular endovascular prostheses are often formed as stent-grafts having a flexible tubular liner or "graft" which is supported by a perforate tubular frame or "stent". The frame perforations define radially expandable structures, while the frame often include metals which are, to some extent, visible under fluoroscopy. To facilitate positioning of endovascular prostheses, it has previously been proposed to coil gold or platinum wires around an element of the perforate frame structure to enhance the visibility of the prosthesis under fluoroscopy. Similarly, it has been suggested that a tube be crimped over an element of the frame. Unfortunately, affixing such structures to the frame may limit or interfere with the radial compressibility of the prosthesis. It can also be difficult to identify the portion of the frame having an enhanced image against the backdrop of the frame itself, and to orient the prosthesis properly based on one or more enhanced frame arms. In one very important improvement, U.S. Patent No. 5,824 042 herein incorporated by reference for all purposes, describes a radiopaque marker having a passage therethrough to facilitate stitching the marker directly to the liner, which overcomes some of the drawbacks suggested above. Unfortunately, attachments of these sutured markers is somewhat expensive.
Alternatively, it has also been suggested to affix radiopaque lines or image markers to bifurcated grafts in the form of fine wire or chain, either woven into the cloth or applied after weaving, or as an inert paint or plastic. However, the liners of endoluminal prostheses should remain highly flexible, typically being folded when the prosthesis is compressed and unfolding during deployment. Wires, chains, or paints which are sufficiently flexible will generally provide only limited-contrast images when the graft is supported by the obscuring frame, and may become detached from the prosthesis once deployed in the body lumen. Moreover, imaging of such thin, flexible, low-contrast markers is particularly difficult when the prosthesis is in the high density, radially compressed configuration and disposed within a catheter, as is generally required for intravascular maneuvering.
For these reasons, it would be desirable to provide improved endoluminal prostheses and methods for their use. It would be particularly desirable to provide endoluminal prostheses having high-contrast orientation indicating imaging markers which do not interfere with radial compression or expansion, and which are securely and reliably attached to the prosthesis without using sutures, adhesives, and/or weaves. It would further be desirable if such markers could clearly indicate both the position and orientation of the prosthesis, ideally while the prosthesis remains compressed in the delivery catheter, but without substantially increasing the size of the delivery system and/or incurring the high costs of known marker attachment techniques.
2- Description of the Background Art
United States Patent No. 5,824,037, the full disclosure of which is hereby incorporated by reference, describes modular prostheses and prosthetic construction methods. Application Serial No. 08/704,960, filed August 29, 1996 (Attorney-Docket No. 16380-003410), also incorporated herein by reference, describes bifurcated modular prosthetic structures and in situ methods for their assembly.
Published PCT patent application WO 95/21,592 describes a bifurcated endoluminal prosthesis including a biftircated stent and a second stent. U.S. Patent No 5,387,235 describes a bifurcated graft having radiopaque lines and markers. TJ.S Patent No. 5,776,180 describes ste s which include fabric coverings and radiopaque markers formed of wire crimped on the end of a stent or a tube disposed around a length of a wire on the stent
SUMMARY OF THE INVENTION The present invention provides improved endoluminal prostheses (and methods for their use) having discrete position indicating elements which facilitate the oπenting and deploying of the prostheses within body lumens. More specifically the endoluminal prostheses includes endovascular prostheses, often formed as stent-grafts having an improved radiopaque image marker to be applied to the graft before the graft is deployed. Typically, the marker is in the form of a flat metal plate resembling a circular disk or "button," however, the shape of the plate may be modified as desired to conform to the needs of the application. The plate may be fastened or secured on to the graft at any desired position using a pair of fastening shanks or tangs which extend parallel to each other outward from a major surface of the plate, in a fashion similar to the fastening shanks of a common staple. The marker, herein referred to as a "staplebutton" marker is operated by forcing the fastening shanks through the graft liner, until an underside of the button rests on the liner. Each shank is then folded down on the other side of the liner, so as to bind the material between the folded fastening shanks and the button.
The staplebutton thus described provides a high-contrast, orientation indicating imaging marker, which does not interfere with radial compression or expansion of an endoluminal prostheses on which it is being used. By using fastening shanks or tangs, the staplebutton can be securely and reliably attached to the liner or any other portion of the prosthesis without fear of the inadvertent detachment of the marker One other advantage of the liner supported marker element is that the marker element can move out of the way of the frame with the liner when the prosthesis is compressed and further, it remains out of the way when the liner (and frame) is deployed. The staplebutton marker can also clearly indicate both the position and orientation of the prosthesis, while the prosthesis remains compressed in the delivery catheter, but without substantially increasing the size of the delivery system.
In a first aspect, the present invention provides a tubular graft comprising a polyester fabric and an imagable body disposed on the liner. The body includes a plate and at least two shanks integral with the plate, the shanks affixing the imagable body on the liner. The imagable body provides a sharp contrast so as to indicate the liner position when the prosthesis is imaged within the patient body. In a preferred aspect, the present invention provides an endoluminal prosthesis for deployment in a body lumen of a patient body. The prosthesis includes a tubular fabric liner having a proximal end, a distal end, and a lumen therebetween. A plurality of imagable bodies are attached to the liner and provide a sharp contrast so as to define a pattern which indicates the prosthesis position when the prosthesis is imaged within the patient body. Each imagable body has a plate and two integral fastening members, which facilitate the attachment of the imagable bodies to the liner.
In another aspect, the present invention provides an endoluminal prosthesis for deployment in a body lumen of a patient body. The prosthesis includes a tubular fabric liner having a proximal end, a distal end, and a lumen therebetween and a radially expandable frame which supports the liner. A plurality of radiopaque marker elements are disposed on the liner. Each marker includes a plate having a first and a second opposed major surface and two fastening members which extend from the second major surface, through the line, and along the plate so that the marker elements are attached to the hner. The marker elements indicate a position of the prosthesis when the prosthesis is imaged within the body lumen.
Advantageously, the imagable bodies described above can be aligned with openings of a perforate frame structure used to support the fabric liner so that at least some of the imagable bodies are visible through the associated openings when the frame is expanded. Advantageously, the markers need not actually be attached to the frame directly. Such imagable bodies are clearly visible when the prosthesis is deployed and can also be sized to produce distinct images even when the frame is compressed within a delivery catheter, but should not interfere with the radial expansion of the frame during deployment. The imagable bodies optionally comprise a radiopaque material, or may alternatively produce enhanced ultrasound images.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 A is a cross-sectional side view of an artery having an exemplary liner having axially constant characteristics.
Fig. IB is a side view of an exemplary cylindrical vascular stent-graft having axially constant characteristics.
Fig. 2 is a perspective view of an exemplary delivery catheter for use with the prostheses of the present invention, with a portion of the distal end broken away to disclose a prostheses therein.
Fig. 3 illustrates a modular branching endoluminal prosthesis assembled from expansible prosthetic modules.
Figs. 4-5B illustrate orientation indicating stent-grafts having a liner that supports marker elements, the marker elements comprising imagable bodies which define a pattern that facilitates orienting and assembling the prostheses in situ when the prosthesis is imaged fluoroscopically within a body lumen.
Figs. 6-6B illustrate a preferred radiopaque marker element comprising an imagable body in the form of a plate having fastening shanks to facilitate attachment of the plate to the liner. Figs- 7 A and 7B illustrate a method for installing the radiopaque marker elements to the liner of an endoluminal prosthesis.
DESCRIPTION OF THE SPECIFIC EMBODIMENTS The present invention provides radially expansible tubular prostheses, particularly grafts, which generally include discrete, marker elements that provide a high- contrast image when viewed under fluoroscopy, ultrasound, or some other surgical imaging modality, so as to facilitate the proper positioning of the prosthesis within a body lumen. The prostheses of the present invention are suitable for a wide variety of therapeutic uses, including grafting portions of the ureter, urethra, trachea, branchi, esophagus, biliary tract, and the like. The present devices and methods will also be useful for the creating of temporary or long term lumens, such as the formation of fistulas. The prosthetic structures of the present invention will find their most immediate use as endovascular prostheses for the treatment of diseases of the vasculature, particularly aneurysms, stenoses, and the like, and are especially well suited for therapies to treat abdominal aortic aneurysms adjacent the aortal/iliac junction. These prostheses will generally be radially expansible from a narrow diameter configuration to facilitate introduction into the body lumen, typically during surgical cutdown or percutaneous introduction procedures.
The prosthetic structures described hereinbelow will find use in axially uniform cylindrical prostheses, in preassembled bifurcated prostheses, and as prosthetic modules which are suitable for selective assembly either prior to deployment, or in situ. Such selective assembly of prosthetic modules to form a customized endoluminal prosthesis is more fully described in co-pending U.S. Patent Application Serial No. 08/704,960 and U.S. Patent No. 5,824,037 the full disclosures of which are herein incorporated by reference.
An exemplary cylindrical graft structure is shown in Fig. 1A. Artery Aj is shown with its lumen forced open by a form of a tubular graft liner 18, having a proximal end, a distal end, and a graft lumen therebetween. Another exemplary cylindrical graft structure 10 is illustrated in Fig. IB. Prostheses 10 comprises a perforate tubular frame 12 which includes a plurality of independent (non-connected) ring frames 14. The tubular frame 12 supports an inner liner 18. Optionally, an outer liner is disposed over the ring frames, either inside of inner liner 18, or in combination therewith. To secure ring frames 14 in place, and to secure the liner to the perforate tubular frame 12, the liner is typically sutured to the frame. A wide variety of alternative liner/frame attachment mechanisms are available, including adhesive bonding, heat welding, ultrasonic welding, and the like. Where inner and outer liners are used, the ring frames may be sandwiched between the liners and held in place by attaching the liners to each other. The prostheses 10 will typically have a length in the range from about 20 mm to 500 mm, preferably from 50 mm to 200 mm, with a relaxed diameter in the range from about 4 mm to 45 mm, preferably being in the range from about 5 mm to 38 mm. Referring now to Fig. 2, an exemplary delivery catheter 30 for use with the endoluminal prostheses of the present invention comprises a tubular cover 32 and a shaft 34. Cover 32 has a central lumen 36 extending from a proximal end 38 to a distal end 40. Shaft 34 is slidably received within central lumen 36 and extends proximally of cover 32. ' A plurality of runners 42 extend distally from shaft 34. Runners 42 line a portion of the inner surface of lumen 36, and slide within the lumen of the shaft. Shaft 34 also has a lumen, in which a core shaft 44 is slidably disposed. Core shaft 44 has a guide wire lumen 46. Nosecone 48 is fixed to the distal end of core shaft 44, and can therefore be manipulated independently of runners 42. Prostheses 10 is radiajly compressed and restrained within the plurality of runners 42. In turn, cover 32 prevents runners 42 from expanding outward. Runners 42 are formed from a hard material, and distribute the expansion load of prostheses 10 over the inner surface of central lumen 36. The deploying force is applied proximally against a slider 50 attached to a distal end 38 of cover 30, while holding a luer fitting 52 at the distal end of shaft 34, thereby withdrawing the cover proximally from over the prostheses. An additional luer adapter 54 at the distal end of core shaft 44 allows the core shaft to be manipulated independently, and to be releasably secured to the shaft 34. Exemplary methods and devices for placement of the prostheses of the present invention are more fully described in Application Serial Nos. 08/862,085, filed May 22, 1997 (Attorney Docket 16380-001 160) and 09/127,666, filed July 31, 1998 (Attorney Docket 16380-001170) and U.S. Patent Nos. 5,683,451 and 5,824,041, the full disclosures of which are incorporated herein by reference.
Although the structures and methods of the present invention will at times be described with reference to simple tubular prostheses having a single lumen, it should be understood that the present invention also generally encompasses more complex branching and modular endoluminal prostheses. Referring to Fig. 3, for example, a branching endoluminal stent-graft 60 is assembled from prosthetic modules selected to match the needs of the diseased vascular system of the patient. A common lumen cuffed prosthetic module 62 seals and anchors the assembled prosthesis in the body lumen, typically within the abdominal aorta below the renal arteries and above the left and right iliac arteries. Y-connector module 64 engages cuffed common lumen module 62, and separates the blood flow for the iliac arteries. First angled branching prosthetic module 66 and second angled branching prosthetic module 68 engage the branch lumens of Y- connector module 64 to direct the luminal flow along first and second branching body lumens.
The modular construction and expansible structure of branching prosthesis 60 allows individual tailoring of the common lumen, first branch lumen, and second branch lumen to match the geometry of the body lumen system. For example, a maximum perimeter of common lumen cuffed module 62 may be selected independently of the branching lumen perimeter limits. Additional sealing cuff structures and methods are described in U.S. Patent No. 5,769,882, the full disclosure of which is also incorporated herein by reference. Referring now to Fig. 4, an orientation indicating bifurcated prosthesis 80 includes a plurality of discrete marker elements 82 which form an orientation indicating pattem 84 when imaged using fluoroscopy, ultrasound, or other imaging modalities. Such bifurcated prostheses will be particularly useful for reinforcing abdominal aortic aneurysms which extend into one or both iliac arteries, and are typically to be used in combination with a secondary prosthetic module engaging port 85 to seal the port to the body lumen system. Toward that end, pattem 86 preferably indicates the axial location of the ends, and the axial and radial orientation of port 85, when the prosthesis is in a radially compressed configuration within a delivery catheter, and after deployment to assist deploying the secondary prosthesis within port 85. Minimizing the radial dimensions of the prosthesis significantly facilitates the intravascular maneuvering of the prosthesis during positioning and deployment. Therefore, it is generally desirable that marker elements 82 have the least possible volume to avoid increases in the delivery catheter cross-section. Furthermore, marker elements should not interfere with the radial expansion of the prosthesis from the radially compressed configuration to the radially expanded configuration, during which perforations 86 of frame 88 expand substantially. On the other hand, the pattern should provide a sharp image, despite the fact that frame 88 will often at least partially obscure the pattern when the prosthesis is imaged.
For the above reasons, marker elements 82 are preferably aligned with perforations 86, ideally being substantially disposed within the perforations to maximize their image contrast against the generally radiographically clear liner 90. Generally, supporting the marker elements with the liner, rather than attaching them directly to the frame, also helps avoid interference between the marker elements and the expansion of the surrounding frame structure. Additionally, supporting the marker elements on the liner so that they are separated from the frame will help to avoid erosion of the frame as the marker elements will not rub against the frame with physiological movement.
Pattern 84 defined by marker elements 82 includes several novel features. A port orientation indicator 92 is preferably disposed adjacent an end of the prosthesis which will be expanded before the port, and helps to verify that the orientation of port 85 will be aligned properly with the intended branching body lumen before the port is expanded in position. Fine rotational alignment of the prosthesis is facilitated by including roughly opposed marker elements 94, so that the preferred radial orientation of the prosthesis can be provided by orienting the imaging mechanism relative to the body lumen system.
A still further feature of pattern 84 is the two axially separated gates 96 adjacent port 85. The axial positions and separation of these gates gives a visual indicator of the allowable prosthetic module overlap when the prosthesis is deployed and imaged in situ. Modular prostheses having less than a predetermined overlap may not be adequately fixed together, while branches which extend too far into the bifurcated prosthesis may lead to an imbalance in the flow between the branches, or may even fold over and substantially block the luminal flow to one or both branches.
Generally, an overlap is acceptable when an end (or an associated overlap marker) of a secondary prosthesis is disposed between the gates. Advantageously, the gates are defined by markers on either side of the port centerline, greatly improving the visibility of the markers when the delivery catheter of a secondary prosthesis enters the port. Furthermore, a pattern including such gates provides a clear demarcation of the target path between the markers when advancing a guidewire and/or a delivery catheter into the port 85 of bifurcated prosthesis 80.
Referring now to Figs. 5A and 5B, branch secondary prosthetic module 100 and trunk secondary prosthetic module 102 also include image markers 82 which define patterns to facilitate axially positioning and radially orienting these modules within a body lumen, particularly with reference to bifurcated prosthesis 80 described above. Each of branch module 100 and trunk module 102 include marker elements 106 which produce an image which is aligned along a prosthetic centerline 104 when the prosthesis is properly positioned relative to the imaging apparatus. Advantageously, such a marker element may be aligned with a guidewire passing through the prosthetic lumen even if no other rotational alignment marker is provided, thereby minimizing the total number of markers. Asymmetric marker elements 108 are radially offset from the centerline markers, preferably defining a radial angle between about 15° and 70° with centerline markers 106, to ensure that the modules are not 180° out of rotational alignment, which could be problematic if the modules have a preferred bend angle or some other asymmetric structure. A roughly 30° radial angle is preferred, as flat thin marker elements will produce smaller images when viewed edge-on that tend to blend into the frame as the angle approaches 90°, while smaller angles will be difficult to differentiate. Furthermore, such significantly off-centerline markers are less likely to be overshadowed by subsequent guidewire or delivery catheter placements. Left and right off-centerline markers may be included to ensure the prosthesis is not roughly 150° out of rotational alignment. The* asymmetric marker elements can also easily be aligned with the port indicator markers 92 or otherwise consistently aligned with some other imagable structure of the bifurcated prosthesis of Fig. 5A. Regardless of the specific radiopaque marker alignment or structure selected, the prostheses of the present invention will often include different materials for the frame and for the marker elements. As described above, the frame material will often comprise a high strength metal, while the marker elements will generally comprise a radiopaque metal or a metal which produces an enhanced ultrasound image. One potential problem with known endoluminal prostheses having such dissimilar metals is that a substantial difference in Electromotive Force (EMF) of adjacent metallic materials may promote corrosion. To avoid this problem, the present invention provides endoluminal prostheses with frames and marker element having similar EMF characteristics. A particularly preferred combination combines frames which include Nitinol® and marker elements which include tantalum. These materials exhibit excellent strength and imagability, respectively, and are of sufficiently similar characteristics to avoid electrolytic corrosion.
A preferred marker element structure comprising an imagable body attached to the liner will be described with reference to Figs. 6-6B. The imagable body here comprises a plate 130 attached to liner 132. Plate 130 includes two opposed major surfaces 131 and 133 and at least two fastening members or shanks 134 and 136 to facilitate the attachment. Plate 130 and shanks 134 and 136, generally comprise a material which provides a high sharp contrast when imaged, so as to indicate the liner position when the prosthesis is imaged within the patient body. Plate 130 typically includes a radiopaque material such as gold, platinum, or other implantable metals. Ideally, plate 130 comprises tantalum having a thickness of at least about .002 inches, preferably being about .01 inches. Such tantalum plates may be mass produced by die cutting or laser cutting sheet stock. In most embodiments, the edges of plates 130 will be rounded to avoid any injury to adjacent tissues, and to avoid cutting any liner or attachment fibers.
The plates are often attached to the outer surface of the liner material to avoid interference with the vascular flow or the generation of thrombus. Advantageously, where the liner is also supported by an external frame 140, the prosthetic lumen remains uninterrupted. Furthermore, where the plates are generally attached along a radius of the liner, they should not substantially interfere with expansion of the liner material.
Plate 130 may include a variety of alternative shapes. For example, plate 130 could be shaped as, but is not limited to, a square, a triangle, an oval, an arrow, a number or a letter. Each shape may correspond to a different application or need.
Referring back to Fig. 5A, for example, a port orientation indicator 92 could be shaped as a circular disk, while gates 96 may be shaped as ovals. Still other marker elements 82 may have plates shaped as arrows to indicate deployment and/or blood flow direction. Regardless of the shape of plate 130, the imagable bodies should be securely and reliably fastened to liner 132. Referring again to Figs. 6A and 6B, as previously mentioned, the imagable bodies includes at least two shanks 134 and 136. Preferably, shanks 134 and 136 are made integral with plate 130. However, the shanks may be separately formed and attached to plate 130 using conventional adhesives techniques such as welding and the like. The shanks 134 and 136 provide the primary means for affixing the imagable body to liner 130. Optionally, however, the shanks can be used to affix marker 82 to external frame 140 within the scope of the present invention.
In a preferred embodiment, each shank 134 and 136 projects outward from plate 130. Shanks 134 and 136 are bent over, in the same direction, at right-angles to plate 130. The cantilevered end of the shanks 135 and 137 each end at a point sufficiently sharp enough to pierce fabric liner 132 without collapsing the shank upon the application of pressure to the marker. Once the shanks pierce liner 132, they are pushed through the liner until second major surface 133 is disposed adjacent liner 132. The shanks are then bent over in a direction toward the center of plate 130, until the shanks are generally parallel to major surface 133. Advantageously, each shank 134 and 136 is cut at right and left opposing angles 139 and 141 so that the shanks lay side-by-side, substantially in the same plane, when the shanks are bent over parallel to the plate. Referring now to Fig. 1, one exemplary method for installing the radiopaque marker elements to the liner of an endoluminal prosthesis includes using an installation tool 200. Installation tool 200 is generally formed of two opposed clamping members 202 and 204. One clamping member has a recessed portion 206 capable of receiving major surface 131 of plate 130. The second clamping member 204 has a recessed portion 210 that is designed \yith a surface feature capable of receiving shanks 134 and 136. In operation, marker 82 -is positioned over a predetermined location on liner 132. Shanks 134 and 136.*are forced to pierce liner 132 and pushed through until major surface 133 is disposed proximate to the liner. The clamping members 202 and 204 are then placed over marker 82 and plate 130 is inserted into recessed portion 206. A clamping force is then brought to bear on plate 130 and shanks 134 and 136 in the directions of arrows 208. The surface features of recessed portion 210 are designed to bend shanks 134 and 136 in a direction towards the center of plate 130 until desired or until the shanks are generally parallel to plate 130. As a result of the clamping, liner 132 is bound between the bent over shanks and major surface 133. Advantageously, except for the clamping tool, nothing else is needed to secure marker 82 to liner 132. Therefore, adhesives, sutures, or other attachment means are not necessary.
Although the exemplary embodiments have been described in some detail, by way of illustration and example, the scope of the present invention is limited solely by the appended claims.

Claims

WHAT IS CLAIMED IS: 1. An endoluminal prosthesis comprising: a fabric liner comprising a polyester fabric; and an imagable body disposed on the liner, the body including a plate and at least two shanks integral with the plate, the shanks affixing the imagable body on the liner, the imagable body providing a sharp contrast so as to indicate the liner position when the prosthesis is imaged within the patient body.
2. A prosthesis as claimed in claim 1 , wherein the fabric liner comprises a tubular graft having a proximal end, a distal end, and a lumen therebetween.
3. A prosthesis as claimed in claim 2, further comprising a radially expandable frame supporting the tubular graft.
4. A prosthesis as claimed in claim 1 , wherein the plate comprises a shape taken from the group consisting of a square, rectangle, circle, triangle, arrow, and oval.
5. A prosthesis as claimed in claim 1, wherein the imagable body is radiopaque.
6. A prosthesis as claimed in claim 1, wherein each shank projects from an opposing edge of the plate and through the liner, the shanks bent over so as to attach the imagable body to the liner.
7. A prosthesis as claimed in claim 1 , wherein each shank is cut at right and left opposing angles so that the arms lay side-by-side when the shanks are bent toward each other along the plate.
8. A prosthesis as claimed in claim 1, wherein the plate comprises first and second opposed major surfaces, wherein the shanks extend from the second major surface, and wherein the second major surface is disposed adjacent the liner.
9. A prosthesis as claimed in claim 1 , wherein the shanks each comprise a pointed end capable of piercing the fabric liner.
10. An endoluminal prosthesis for deployment in a body lumen of a patient body, the prosthesis comprising: a tubular fabric liner having a proximal end, a distal end, and a lumen therebetween; and a plurality of imagable bodies attached to the liner, each imagable body having a plate and two integral fastening members to attach of the imagable bodies to the liner, the imagable bodies providing a sharp contrast to define a pattem so as to indicate the prosthesis position when the prosthesis is imaged within the patient body.
11. A prosthesis as claimed in claim 10, further comprising a radially expandable frame supporting the liner.
12. A prosthesis as' claimed in claim 11, wherein the frame comprises a tube defining a plurality of radial openings when expanded, and wherein images of at least some of the imagable bodies are visible through associated openings of the expanded frame.
13. A prosthesis as claimed in claim 10, wherein the plate comprises first and second opposed major surfaces, wherein the fastening members extend from the second major surface, and wherein the second major surface is disposed adjacent the liner.
14. A prosthesis as claimed in claim 10, wherein each fastening member is cut at right and left opposing angles so that the members lay side-by-side when the arms are bent over in the same direction parallel to the plate.
15. A prosthesis as claimed in claim 10, wherein the imagable bodies are radiopaque.
16. A prosthesis as in claim 10, wherein the plate comprises a material taken from the group consisting of tantalum, platinum, and gold
17. A prosthesis as claimed in claim 10, wherein the imagable bodies provide enhanced ultrasound images.
18. An endoluminal prosthesis for deployment in a body lumen of a atient b e esis c risin : a tubular fabric liner having a proximal end, a distal end, and a lumen therebetween; a radially expandable frame.supporting the liner; and a plurality of radiopaque marker elements, each marker element comprising a plate having a first and a second opposed major surface, with two fastening members extending from the second major surface, through the liner, and along the plate so as to affix the marker element to the liver, the marker elements indicating a position of the prosthesis when the prosthesis is imaged within the body lumen.
19. A prosthesis as in claim 18, wherein the marker elements are not directly attached to the frame.
20. A prosthesis as 'in claim 18, wherein the marker elements are not in contact with the frame when the frame is radially expanded.
21. A method for fabricating a stent-graft, the method comprising: affixing a marker plate to a liner by piercing the liner with a pair of shanks, the shanks extending from the plate, and bending the shanks; and supporting the liner with a radially expandable frame.
PCT/US2001/003407 2000-02-03 2001-02-02 Endoluminal prostheses having radiopaque marker WO2001056503A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/497,372 US6361557B1 (en) 1999-02-05 2000-02-03 Staplebutton radiopaque marker
US09/497,372 2000-02-03

Publications (1)

Publication Number Publication Date
WO2001056503A1 true WO2001056503A1 (en) 2001-08-09

Family

ID=23976591

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/003407 WO2001056503A1 (en) 2000-02-03 2001-02-02 Endoluminal prostheses having radiopaque marker

Country Status (2)

Country Link
US (1) US6361557B1 (en)
WO (1) WO2001056503A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021173126A1 (en) * 2020-02-26 2021-09-02 C.R. Bard, Inc. Stent grafts having a radiopaque marker and methods of producing

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051020A (en) * 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
DE69732794T2 (en) * 1996-01-05 2006-04-06 Medtronic, Inc., Minneapolis EXPANDABLE ENDOLUMINARY PROSTHESIS
US8728143B2 (en) * 1996-06-06 2014-05-20 Biosensors International Group, Ltd. Endoprosthesis deployment system for treating vascular bifurcations
US7238197B2 (en) * 2000-05-30 2007-07-03 Devax, Inc. Endoprosthesis deployment system for treating vascular bifurcations
US7686846B2 (en) * 1996-06-06 2010-03-30 Devax, Inc. Bifurcation stent and method of positioning in a body lumen
US6951572B1 (en) * 1997-02-20 2005-10-04 Endologix, Inc. Bifurcated vascular graft and method and apparatus for deploying same
US6503271B2 (en) * 1998-01-09 2003-01-07 Cordis Corporation Intravascular device with improved radiopacity
US6656215B1 (en) * 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
US6887268B2 (en) * 1998-03-30 2005-05-03 Cordis Corporation Extension prosthesis for an arterial repair
US8177762B2 (en) * 1998-12-07 2012-05-15 C. R. Bard, Inc. Septum including at least one identifiable feature, access ports including same, and related methods
US6660030B2 (en) * 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US6328689B1 (en) 2000-03-23 2001-12-11 Spiration, Inc., Lung constriction apparatus and method
US20030139803A1 (en) * 2000-05-30 2003-07-24 Jacques Sequin Method of stenting a vessel with stent lumenal diameter increasing distally
US7101391B2 (en) * 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US7229472B2 (en) * 2000-11-16 2007-06-12 Cordis Corporation Thoracic aneurysm repair prosthesis and system
US6942692B2 (en) * 2000-11-16 2005-09-13 Cordis Corporation Supra-renal prosthesis and renal artery bypass
US6636758B2 (en) * 2001-05-01 2003-10-21 Concentric Medical, Inc. Marker wire and process for using it
US6860847B2 (en) * 2001-07-10 2005-03-01 Spiration, Inc. Constriction device viewable under X ray fluoroscopy
DE60236093D1 (en) * 2001-07-26 2010-06-02 Merit Medical Systems Inc REMOVABLE STENT
US20030225448A1 (en) * 2002-05-28 2003-12-04 Scimed Life Systems, Inc. Polar radiopaque marker for stent
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
US20040093068A1 (en) * 2002-07-24 2004-05-13 Bergen Lee C. Abdominal stent graft and delivery system
US8920826B2 (en) * 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
US6878162B2 (en) 2002-08-30 2005-04-12 Edwards Lifesciences Ag Helical stent having improved flexibility and expandability
US9561123B2 (en) 2002-08-30 2017-02-07 C.R. Bard, Inc. Highly flexible stent and method of manufacture
US20040054403A1 (en) * 2002-09-18 2004-03-18 Israel Henry M Angular orientation of a stent
US7331986B2 (en) * 2002-10-09 2008-02-19 Boston Scientific Scimed, Inc. Intraluminal medical device having improved visibility
US20040093056A1 (en) * 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7637942B2 (en) * 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7527644B2 (en) * 2002-11-05 2009-05-05 Alveolus Inc. Stent with geometry determinated functionality and method of making the same
US7959671B2 (en) * 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
AU2002356575B2 (en) * 2002-11-08 2009-07-16 Jean-Claude Laborde Endoprosthesis for vascular bifurcation
US7637934B2 (en) * 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
CA2553693A1 (en) * 2004-01-22 2005-08-11 Isoflux, Inc. Radiopaque coating for biomedical devices
US20070106374A1 (en) * 2004-01-22 2007-05-10 Isoflux, Inc. Radiopaque coating for biomedical devices
US8002822B2 (en) * 2004-01-22 2011-08-23 Isoflux, Inc. Radiopaque coating for biomedical devices
JP2008504104A (en) 2004-06-28 2008-02-14 イソフラックス・インコーポレイテッド Porous coating for biomedical implants
EP1765458A2 (en) * 2004-07-13 2007-03-28 Isoflux, Inc. Porous coatings on electrodes for biomedical implants
US9387313B2 (en) * 2004-08-03 2016-07-12 Interventional Spine, Inc. Telescopic percutaneous tissue dilation systems and related methods
US20060074480A1 (en) 2004-09-01 2006-04-06 Pst, Llc Stent and method for manufacturing the stent
WO2006096686A1 (en) 2005-03-04 2006-09-14 C.R. Bard, Inc. Access port identification systems and methods
US9474888B2 (en) 2005-03-04 2016-10-25 C. R. Bard, Inc. Implantable access port including a sandwiched radiopaque insert
US8029482B2 (en) 2005-03-04 2011-10-04 C. R. Bard, Inc. Systems and methods for radiographically identifying an access port
US7947022B2 (en) 2005-03-04 2011-05-24 C. R. Bard, Inc. Access port identification systems and methods
US8147455B2 (en) 2005-04-27 2012-04-03 C. R. Bard, Inc. Infusion apparatuses and methods of use
US10307581B2 (en) 2005-04-27 2019-06-04 C. R. Bard, Inc. Reinforced septum for an implantable medical device
EP1896117B1 (en) 2005-04-27 2011-01-12 C.R.Bard, Inc. Power injector system for injecting contrast media into an intravenous line
US20070156230A1 (en) 2006-01-04 2007-07-05 Dugan Stephen R Stents with radiopaque markers
WO2007095466A2 (en) 2006-02-14 2007-08-23 Angiomed Gmbh & Co. Medizintechnik Kg Highly flexible stent and method of manufacture
US20130325104A1 (en) 2006-05-26 2013-12-05 Abbott Cardiovascular Systems Inc. Stents With Radiopaque Markers
US8414637B2 (en) * 2006-09-08 2013-04-09 Boston Scientific Scimed, Inc. Stent
US9642986B2 (en) 2006-11-08 2017-05-09 C. R. Bard, Inc. Resource information key for an insertable medical device
US9265912B2 (en) 2006-11-08 2016-02-23 C. R. Bard, Inc. Indicia informative of characteristics of insertable medical devices
US8105382B2 (en) 2006-12-07 2012-01-31 Interventional Spine, Inc. Intervertebral implant
US8523931B2 (en) * 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
US8333799B2 (en) * 2007-02-12 2012-12-18 C. R. Bard, Inc. Highly flexible stent and method of manufacture
US8328865B2 (en) 2007-02-12 2012-12-11 C. R. Bard, Inc. Highly flexible stent and method of manufacture
US20080243226A1 (en) * 2007-03-30 2008-10-02 Fernandez Jose E Implantable stents with radiopaque markers and methods for manufacturing the same
US7810223B2 (en) * 2007-05-16 2010-10-12 Boston Scientific Scimed, Inc. Method of attaching radiopaque markers to intraluminal medical devices, and devices formed using the same
US8257325B2 (en) * 2007-06-20 2012-09-04 Medical Components, Inc. Venous access port with molded and/or radiopaque indicia
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
US9610432B2 (en) 2007-07-19 2017-04-04 Innovative Medical Devices, Llc Venous access port assembly with X-ray discernable indicia
EP2180915B1 (en) 2007-07-19 2017-10-04 Medical Components, Inc. Venous access port assembly with x-ray discernable indicia
US9579496B2 (en) 2007-11-07 2017-02-28 C. R. Bard, Inc. Radiopaque and septum-based indicators for a multi-lumen implantable port
US7811623B2 (en) * 2007-12-21 2010-10-12 Innovatech, Llc Marked precoated medical device and method of manufacturing same
US8048471B2 (en) * 2007-12-21 2011-11-01 Innovatech, Llc Marked precoated medical device and method of manufacturing same
US8231926B2 (en) 2007-12-21 2012-07-31 Innovatech, Llc Marked precoated medical device and method of manufacturing same
US7714217B2 (en) 2007-12-21 2010-05-11 Innovatech, Llc Marked precoated strings and method of manufacturing same
US8231927B2 (en) * 2007-12-21 2012-07-31 Innovatech, Llc Marked precoated medical device and method of manufacturing same
CN101909548B (en) 2008-01-17 2014-07-30 斯恩蒂斯有限公司 An expandable intervertebral implant and associated method of manufacturing the same
US8221494B2 (en) 2008-02-22 2012-07-17 Endologix, Inc. Apparatus and method of placement of a graft or graft system
WO2009124269A1 (en) 2008-04-05 2009-10-08 Synthes Usa, Llc Expandable intervertebral implant
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
US20090318948A1 (en) * 2008-04-22 2009-12-24 Coherex Medical, Inc. Device, system and method for aneurysm embolization
JP5134729B2 (en) 2008-07-01 2013-01-30 エンドロジックス、インク Catheter system
US9180278B2 (en) * 2008-08-11 2015-11-10 Terumo Kabushiki Kaisha Medical instrument
US8998981B2 (en) 2008-09-15 2015-04-07 Medtronic, Inc. Prosthetic heart valve having identifiers for aiding in radiographic positioning
WO2010051494A1 (en) * 2008-10-31 2010-05-06 C.R. Bard, Inc. Systems and methods for identifying an acess port
US11890443B2 (en) 2008-11-13 2024-02-06 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US8932271B2 (en) 2008-11-13 2015-01-13 C. R. Bard, Inc. Implantable medical devices including septum-based indicators
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US20100274276A1 (en) * 2009-04-22 2010-10-28 Ricky Chow Aneurysm treatment system, device and method
EP2429452B1 (en) 2009-04-28 2020-01-15 Endologix, Inc. Endoluminal prosthesis system
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
EP2451512A1 (en) 2009-07-07 2012-05-16 C.R. Bard Inc. Extensible internal bolster for a medical device
US8491646B2 (en) 2009-07-15 2013-07-23 Endologix, Inc. Stent graft
WO2011017123A2 (en) 2009-07-27 2011-02-10 Endologix, Inc. Stent graft
JP2013510652A (en) 2009-11-17 2013-03-28 シー・アール・バード・インコーポレーテッド Overmolded access port including locking feature and identification feature
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US8808353B2 (en) 2010-01-30 2014-08-19 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds having a low crossing profile
US8568471B2 (en) 2010-01-30 2013-10-29 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
US20110218617A1 (en) * 2010-03-02 2011-09-08 Endologix, Inc. Endoluminal vascular prosthesis
US9907560B2 (en) 2010-06-24 2018-03-06 DePuy Synthes Products, Inc. Flexible vertebral body shavers
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
TW201215379A (en) 2010-06-29 2012-04-16 Synthes Gmbh Distractible intervertebral implant
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US20120109279A1 (en) 2010-11-02 2012-05-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
EP2658484A1 (en) 2010-12-30 2013-11-06 Boston Scientific Scimed, Inc. Multi stage opening stent designs
USD676955S1 (en) 2010-12-30 2013-02-26 C. R. Bard, Inc. Implantable access port
USD682416S1 (en) 2010-12-30 2013-05-14 C. R. Bard, Inc. Implantable access port
CN105232195B (en) 2011-03-01 2018-06-08 恩朵罗杰克斯股份有限公司 Delivery catheter system
WO2012119037A1 (en) 2011-03-03 2012-09-07 Boston Scientific Scimed, Inc. Stent with reduced profile
JP2014511247A (en) 2011-03-03 2014-05-15 ボストン サイエンティフィック サイムド,インコーポレイテッド Low strain high strength stent
US8900652B1 (en) 2011-03-14 2014-12-02 Innovatech, Llc Marked fluoropolymer surfaces and method of manufacturing same
US8726483B2 (en) 2011-07-29 2014-05-20 Abbott Cardiovascular Systems Inc. Methods for uniform crimping and deployment of a polymer scaffold
US9233015B2 (en) 2012-06-15 2016-01-12 Trivascular, Inc. Endovascular delivery system with an improved radiopaque marker scheme
WO2014018098A1 (en) 2012-07-26 2014-01-30 DePuy Synthes Products, LLC Expandable implant
US20140067069A1 (en) 2012-08-30 2014-03-06 Interventional Spine, Inc. Artificial disc
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
WO2014143974A1 (en) * 2013-03-15 2014-09-18 Bio-Tree Systems, Inc. Methods and system for linking geometry obtained from images
EP2996580B1 (en) 2013-04-11 2020-02-12 Balt Usa Llc Radiopaque devices for cerebral aneurysm repair
US10524904B2 (en) * 2013-07-11 2020-01-07 Medtronic, Inc. Valve positioning device
US9999527B2 (en) * 2015-02-11 2018-06-19 Abbott Cardiovascular Systems Inc. Scaffolds having radiopaque markers
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9700443B2 (en) 2015-06-12 2017-07-11 Abbott Cardiovascular Systems Inc. Methods for attaching a radiopaque marker to a scaffold
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
US9913727B2 (en) 2015-07-02 2018-03-13 Medos International Sarl Expandable implant
JP6426068B2 (en) * 2015-08-10 2018-11-21 朝日インテック株式会社 Catheter and balloon catheter
JP6995789B2 (en) 2016-06-28 2022-01-17 イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー Expandable and angle adjustable intervertebral cage
JP7019616B2 (en) 2016-06-28 2022-02-15 イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー Expandable and angle adjustable intervertebral cage with range of motion joints
US10537436B2 (en) 2016-11-01 2020-01-21 DePuy Synthes Products, Inc. Curved expandable cage
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
CA3183162A1 (en) 2020-06-19 2021-12-23 Jake Anthony Sganga Systems and methods for guidance of intraluminal devices within the vasculature
US20220061985A1 (en) * 2020-08-25 2022-03-03 Medtronic, Inc. Devices and methods for multi-alignment of implantable medical devices
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US11707332B2 (en) 2021-07-01 2023-07-25 Remedy Robotics, Inc. Image space control for endovascular tools
WO2023278789A1 (en) 2021-07-01 2023-01-05 Remedy Robotics, Inc. Vision-based position and orientation determination for endovascular tools

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562728A (en) * 1983-12-09 1996-10-08 Endovascular Tech Inc Endovascular grafting apparatus, system and method and devices for use therewith
WO1997037616A2 (en) * 1996-04-05 1997-10-16 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
US5749920A (en) * 1983-12-09 1998-05-12 Endovascular Technologies, Inc. Multicapsule intraluminal grafting system and method
US5824039A (en) * 1991-04-11 1998-10-20 Endovascular Technologies, Inc. Endovascular graft having bifurcation and apparatus and method for deploying the same
US5824044A (en) * 1994-05-12 1998-10-20 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system
EP1025811A2 (en) * 1999-02-05 2000-08-09 Medtronic, Inc. Endoluminal prosthesis having radiopaque marker
US6102938A (en) * 1997-06-17 2000-08-15 Medtronic Inc. Endoluminal prosthetic bifurcation shunt

Family Cites Families (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308368A (en) 1884-11-25 Geobge w
US66968A (en) * 1867-07-23 kendig
US269882A (en) 1883-01-02 Metallic clamp
US3618614A (en) 1969-05-06 1971-11-09 Scient Tube Products Inc Nontoxic radiopaque multiwall medical-surgical tubings
US3757768A (en) 1972-04-07 1973-09-11 Medical Evaluation Devices And Manipulable spring guide-catheter and tube for intravenous feeding
US4202349A (en) 1978-04-24 1980-05-13 Jones James W Radiopaque vessel markers
CA1153264A (en) 1979-02-08 1983-09-06 Hidenaga Yoshimura Medical vascular guide wire and self-guiding type catheter
US4279252A (en) 1979-08-24 1981-07-21 Martin Michael T X-ray scaling catheter
US4657024A (en) 1980-02-04 1987-04-14 Teleflex Incorporated Medical-surgical catheter
US4588399A (en) 1980-05-14 1986-05-13 Shiley Incorporated Cannula with radiopaque tip
US4430083A (en) 1981-03-06 1984-02-07 American Hospital Supply Corporation Infusion catheter
US4662404A (en) 1981-05-15 1987-05-05 Leveen Harry H Flexible tubing
US4464176A (en) 1982-06-04 1984-08-07 Mallinckrodt, Inc. Blood vessel catheter for medicine delivery and method of manufacture
US4469483A (en) 1982-08-25 1984-09-04 Baxter Travenol Laboratories, Inc. Radiopaque catheter
US4545390A (en) 1982-09-22 1985-10-08 C. R. Bard, Inc. Steerable guide wire for balloon dilatation procedure
US4456017A (en) 1982-11-22 1984-06-26 Cordis Corporation Coil spring guide with deflectable tip
USRE33911E (en) 1983-07-13 1992-05-05 Advanced Cardiovascular Systems, Inc. Catheter guide wire with short spring tip and method of using the same
US4538622A (en) 1983-11-10 1985-09-03 Advanced Cardiovascular Systems, Inc. Guide wire for catheters
US5275622A (en) 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
CH661199A5 (en) 1983-12-22 1987-07-15 Sulzer Ag MARKING IMPLANT.
US4636346A (en) 1984-03-08 1987-01-13 Cordis Corporation Preparing guiding catheter
US4617932A (en) 1984-04-25 1986-10-21 Elliot Kornberg Device and method for performing an intraluminal abdominal aortic aneurysm repair
US4577637A (en) 1984-07-13 1986-03-25 Argon Medical Corp. Flexible metal radiopaque indicator and plugs for catheters
US4619274A (en) 1985-04-18 1986-10-28 Advanced Cardiovascular Systems, Inc. Torsional guide wire with attenuated diameter
US4721117A (en) 1986-04-25 1988-01-26 Advanced Cardiovascular Systems, Inc. Torsionally stabilized guide wire with outer jacket
US4798598A (en) 1986-05-23 1989-01-17 Sarcem S.A. Guide for a catheter
US4938220A (en) 1986-08-01 1990-07-03 Advanced Cardiovascular Systems, Inc. Catheter with split tip marker and method of manufacture
US4821722A (en) 1987-01-06 1989-04-18 Advanced Cardiovascular Systems, Inc. Self-venting balloon dilatation catheter and method
US4763647A (en) 1987-01-06 1988-08-16 C. R. Bard, Inc. Dual coil steerable guidewire
US4757827A (en) 1987-02-17 1988-07-19 Versaflex Delivery Systems Inc. Steerable guidewire with deflectable tip
US4815478A (en) 1987-02-17 1989-03-28 Medtronic Versaflex, Inc. Steerable guidewire with deflectable tip
US5105818A (en) 1987-04-10 1992-04-21 Cardiometric, Inc. Apparatus, system and method for measuring spatial average velocity and/or volumetric flow of blood in a vessel and screw joint for use therewith
US4793359A (en) 1987-04-24 1988-12-27 Gv Medical, Inc. Centering balloon structure for transluminal angioplasty catheter
US4796637A (en) 1987-06-17 1989-01-10 Victory Engineering Company Radiopaque marker for stereotaxic catheter
US4817613A (en) 1987-07-13 1989-04-04 Devices For Vascular Intervention, Inc. Guiding catheter
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US4867174A (en) 1987-11-18 1989-09-19 Baxter Travenol Laboratories, Inc. Guidewire for medical use
US4846186A (en) 1988-01-12 1989-07-11 Cordis Corporation Flexible guidewire
US4895168A (en) 1988-01-21 1990-01-23 Schneider (Usa) Inc., A Pfizer Company Guidewire with movable core and external tubular safety cover
US4873983A (en) 1988-01-27 1989-10-17 Advanced Biomedical Devices, Inc. Steerable guidewire for vascular system
US4884579A (en) 1988-04-18 1989-12-05 Target Therapeutics Catheter guide wire
US4898591A (en) 1988-08-09 1990-02-06 Mallinckrodt, Inc. Nylon-PEBA copolymer catheter
JP2836878B2 (en) 1988-08-24 1998-12-14 スリピアン,マービン,ジェイ Intraluminal sealing with biodegradable polymer material
US5456251A (en) 1988-08-26 1995-10-10 Mountpelier Investments, S.A. Remote sensing tonometric catheter apparatus and method
US4906244A (en) 1988-10-04 1990-03-06 Cordis Corporation Balloons for medical devices and fabrication thereof
US5464438A (en) 1988-10-05 1995-11-07 Menaker; Gerald J. Gold coating means for limiting thromboses in implantable grafts
US5065769A (en) 1988-11-23 1991-11-19 Boston Scientific Corporation Small diameter guidewires of multi-filar, cross-wound coils
US5081997A (en) 1989-03-09 1992-01-21 Vance Products Incorporated Echogenic devices, material and method
US4957110A (en) 1989-03-17 1990-09-18 C. R. Bard, Inc. Steerable guidewire having electrodes for measuring vessel cross-section and blood flow
US4922924A (en) 1989-04-27 1990-05-08 C. R. Bard, Inc. Catheter guidewire with varying radiopacity
US5063935A (en) 1989-04-27 1991-11-12 C. R. Bard, Inc. Catheter guidewire with varying radiopacity
US5045072A (en) 1989-06-13 1991-09-03 Cordis Corporation Catheter having highly radiopaque, flexible tip
US4981470A (en) 1989-06-21 1991-01-01 Synectics Medical, Inc. Intraesophageal catheter with pH sensor
CA2019063E (en) 1989-06-29 2000-01-04 Brian L. Bates Hydrophilically coated flexible wire guide
US4990138A (en) 1989-07-18 1991-02-05 Baxter International Inc. Catheter apparatus, and compositions useful for producing same
US5144959A (en) 1989-08-15 1992-09-08 C. R. Bard, Inc. Catheter guidewire with varying radiopacity
IE73670B1 (en) 1989-10-02 1997-07-02 Medtronic Inc Articulated stent
US5084022A (en) 1989-10-04 1992-01-28 Lake Region Manufacturing Company, Inc. Graduated guidewire
US5209730A (en) 1989-12-19 1993-05-11 Scimed Life Systems, Inc. Method for placement of a balloon dilatation catheter across a stenosis and apparatus therefor
US5095915A (en) 1990-03-19 1992-03-17 Target Therapeutics Guidewire with flexible distal tip
US5147315A (en) 1990-04-06 1992-09-15 C. R. Bard, Inc. Access catheter and system for use in the female reproductive system
US5147317A (en) 1990-06-04 1992-09-15 C.R. Bard, Inc. Low friction varied radiopacity guidewire
US5069217A (en) 1990-07-09 1991-12-03 Lake Region Manufacturing Co., Inc. Steerable guide wire
US5034005A (en) 1990-07-09 1991-07-23 Appling William M Radiopaque marker
US5040543A (en) 1990-07-25 1991-08-20 C. R. Bard, Inc. Movable core guidewire
US5250034A (en) 1990-09-17 1993-10-05 E-Z-Em, Inc. Pressure responsive valve catheter
DE9116881U1 (en) 1990-10-09 1994-07-07 Cook Inc Percutaneous stent
US5178158A (en) 1990-10-29 1993-01-12 Boston Scientific Corporation Convertible guidewire-catheter with soft tip
US5211636A (en) 1990-10-31 1993-05-18 Lake Region Manufacturing Co., Inc. Steerable infusion guide wire
US5160559A (en) 1990-10-31 1992-11-03 Scimed Life Systems, Inc. Method for forming a guide catheter tip bond
US5174302A (en) 1990-12-04 1992-12-29 Cordis Corporation Variable radiopacity guidewire with spaced highly radiopaque regions
FR2671009B1 (en) 1990-12-28 1993-03-12 Nivarox Sa GUIDE SUPPORT FOR CATHETER.
US5184627A (en) 1991-01-18 1993-02-09 Boston Scientific Corporation Infusion guidewire including proximal stiffening sheath
US5628783A (en) 1991-04-11 1997-05-13 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system and method
US5195969A (en) 1991-04-26 1993-03-23 Boston Scientific Corporation Co-extruded medical balloons and catheter using such balloons
US5228453A (en) 1991-05-07 1993-07-20 Target Therapeutics, Inc. Catheter guide wire
US5241970A (en) 1991-05-17 1993-09-07 Wilson-Cook Medical, Inc. Papillotome/sphincterotome procedures and a wire guide specially
US5256158A (en) 1991-05-17 1993-10-26 Act Medical, Inc. Device having a radiopaque marker for endoscopic accessories and method of making same
US5234416A (en) 1991-06-06 1993-08-10 Advanced Cardiovascular Systems, Inc. Intravascular catheter with a nontraumatic distal tip
CA2068584C (en) 1991-06-18 1997-04-22 Paul H. Burmeister Intravascular guide wire and method for manufacture thereof
US5769830A (en) 1991-06-28 1998-06-23 Cook Incorporated Soft tip guiding catheter
US5221270A (en) 1991-06-28 1993-06-22 Cook Incorporated Soft tip guiding catheter
US5151105A (en) 1991-10-07 1992-09-29 Kwan Gett Clifford Collapsible vessel sleeve implant
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5387235A (en) 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
EP0539237A1 (en) 1991-10-25 1993-04-28 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting
US5253653A (en) 1991-10-31 1993-10-19 Boston Scientific Corp. Fluoroscopically viewable guidewire for catheters
US5395349A (en) 1991-12-13 1995-03-07 Endovascular Technologies, Inc. Dual valve reinforced sheath and method
US5405004A (en) 1992-03-23 1995-04-11 Vest; Gary W. Tool and parts tray
US5259393A (en) 1992-05-13 1993-11-09 Cordis Corporation Guidewire having controlled radiopacity tip
US5584821A (en) 1992-06-02 1996-12-17 E-Z-Em, Inc. Soft tip catheter
US5366473A (en) 1992-08-18 1994-11-22 Ultrasonic Sensing And Monitoring Systems, Inc. Method and apparatus for applying vascular grafts
US5267574A (en) 1992-09-10 1993-12-07 Cordis Corporation Guidewire with spring and a heat shrinkable connection
US5300025A (en) 1992-09-30 1994-04-05 Advanced Cardiovascular Systems, Inc. Dilatation catheter having a coil supported inflation lumen
US5342348A (en) 1992-12-04 1994-08-30 Kaplan Aaron V Method and device for treating and enlarging body lumens
US5374286A (en) 1993-03-31 1994-12-20 Medtronic, Inc. Torque indicator for fixed screw leads
US5300048A (en) 1993-05-12 1994-04-05 Sabin Corporation Flexible, highly radiopaque plastic material catheter
US5344402A (en) 1993-06-30 1994-09-06 Cardiovascular Dynamics, Inc. Low profile perfusion catheter
US5419324A (en) 1993-11-24 1995-05-30 Endovascular Technologies, Inc. Radiological marker board with movable indicators
US5429617A (en) 1993-12-13 1995-07-04 The Spectranetics Corporation Radiopaque tip marker for alignment of a catheter within a body
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5643312A (en) 1994-02-25 1997-07-01 Fischell Robert Stent having a multiplicity of closed circular structures
US5545138A (en) 1994-02-28 1996-08-13 Medtronic, Inc. Adjustable stiffness dilatation catheter
US5429597A (en) 1994-03-01 1995-07-04 Boston Scientific Corporation Kink resistant balloon catheter and method for use
US5485667A (en) 1994-03-03 1996-01-23 Kleshinski; Stephen J. Method for attaching a marker to a medical instrument
EP0679372B1 (en) 1994-04-25 1999-07-28 Advanced Cardiovascular Systems, Inc. Radiopaque stent markers
US5509910A (en) 1994-05-02 1996-04-23 Medtronic, Inc. Method of soft tip attachment for thin walled catheters
US5403292A (en) 1994-05-18 1995-04-04 Schneider (Usa) Inc. Thin wall catheter having enhanced torqueability characteristics
US5476508A (en) 1994-05-26 1995-12-19 Tfx Medical Stent with mutually interlocking filaments
US5480383A (en) 1994-05-27 1996-01-02 Advanced Cardiovascular Systems, Inc. Dilation catheter with a smooth transition between a stiff proximal portion and a flexible distal portion
US5683451A (en) 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
EP0792627B2 (en) 1994-06-08 2003-10-29 Cardiovascular Concepts, Inc. System for forming a bifurcated graft
US5542937A (en) 1994-06-24 1996-08-06 Target Therapeutics, Inc. Multilumen extruded catheter
US5569221A (en) 1994-07-07 1996-10-29 Ep Technologies, Inc. Catheter component bond and method
CA2147547C (en) 1994-08-02 2006-12-19 Peter J. Schmitt Thinly woven flexible graft
US5458639A (en) 1994-08-05 1995-10-17 Medtronic, Inc. Catheter balloon distal bond
US5575817A (en) 1994-08-19 1996-11-19 Martin; Eric C. Aorto femoral bifurcation graft and method of implantation
US5470315A (en) 1994-09-20 1995-11-28 Scimed Life Systems, Inc. Over-the-wire type balloon catheter with proximal hypotube
AU3498295A (en) 1994-09-26 1996-04-19 Medtronic, Inc. Cathether flexible distal tip
IL115755A0 (en) 1994-10-27 1996-01-19 Medinol Ltd X-ray visible stent
US5658264A (en) 1994-11-10 1997-08-19 Target Therapeutics, Inc. High performance spiral-wound catheter
US5545151A (en) 1994-11-22 1996-08-13 Schneider (Usa) Inc Catheter having hydrophobic properties
US5599326A (en) 1994-12-20 1997-02-04 Target Therapeutics, Inc. Catheter with multi-layer section
WO1996020750A1 (en) 1995-01-04 1996-07-11 Medtronic, Inc. Improved method of soft tip forming
US5662675A (en) 1995-02-24 1997-09-02 Intervascular, Inc. Delivery catheter assembly
US5549552A (en) 1995-03-02 1996-08-27 Scimed Life Systems, Inc. Balloon dilation catheter with improved pushability, trackability and crossability
US5891112A (en) 1995-04-28 1999-04-06 Target Therapeutics, Inc. High performance superelastic alloy braid reinforced catheter
US5658263A (en) 1995-05-18 1997-08-19 Cordis Corporation Multisegmented guiding catheter for use in medical catheter systems
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
ATE192346T1 (en) 1995-06-22 2000-05-15 Schneider Europ Gmbh MEDICINAL DEVICE FOR THE TREATMENT OF A PART OF A BODY VESSEL USING IONIZATION RADIATION
US5582619A (en) 1995-06-30 1996-12-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US5769882A (en) 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US5603991A (en) 1995-09-29 1997-02-18 Target Therapeutics, Inc. Method for coating catheter lumens
US5824037A (en) 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
US5871468A (en) 1996-04-24 1999-02-16 Medtronic, Inc. Medical catheter with a high pressure/low compliant balloon
US5690120A (en) 1996-05-24 1997-11-25 Sarcos, Inc. Hybrid catheter guide wire apparatus
US5913848A (en) 1996-06-06 1999-06-22 Luther Medical Products, Inc. Hard tip over-the-needle catheter and method of manufacturing the same
US5876376A (en) 1996-12-09 1999-03-02 Medtronic, Inc Catheter balloon bonding stopper
US5791036A (en) 1996-12-23 1998-08-11 Schneider (Usa) Inc Catheter transition system
US5769819A (en) 1997-04-24 1998-06-23 Medtronic, Inc. Catheter distal tip component
US5741327A (en) 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
US6179811B1 (en) 1997-11-25 2001-01-30 Medtronic, Inc. Imbedded marker and flexible guide wire shaft
US6068622A (en) 1998-02-10 2000-05-30 Medtronic Inc. Single piece hub/strain relief that can be injection molded over a shaft
US6245053B1 (en) 1998-11-09 2001-06-12 Medtronic, Inc. Soft tip guiding catheter and method of fabrication

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562728A (en) * 1983-12-09 1996-10-08 Endovascular Tech Inc Endovascular grafting apparatus, system and method and devices for use therewith
US5749920A (en) * 1983-12-09 1998-05-12 Endovascular Technologies, Inc. Multicapsule intraluminal grafting system and method
US5824039A (en) * 1991-04-11 1998-10-20 Endovascular Technologies, Inc. Endovascular graft having bifurcation and apparatus and method for deploying the same
US5824044A (en) * 1994-05-12 1998-10-20 Endovascular Technologies, Inc. Bifurcated multicapsule intraluminal grafting system
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
WO1997037616A2 (en) * 1996-04-05 1997-10-16 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5824042A (en) * 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US6102938A (en) * 1997-06-17 2000-08-15 Medtronic Inc. Endoluminal prosthetic bifurcation shunt
EP1025811A2 (en) * 1999-02-05 2000-08-09 Medtronic, Inc. Endoluminal prosthesis having radiopaque marker

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021173126A1 (en) * 2020-02-26 2021-09-02 C.R. Bard, Inc. Stent grafts having a radiopaque marker and methods of producing
JP2023507672A (en) * 2020-02-26 2023-02-24 シー・アール・バード・インコーポレーテッド Stent graft with radiopaque markers and method of manufacture
JP7255033B2 (en) 2020-02-26 2023-04-10 シー・アール・バード・インコーポレーテッド Stent graft with radiopaque markers and method of manufacture

Also Published As

Publication number Publication date
US6361557B1 (en) 2002-03-26

Similar Documents

Publication Publication Date Title
US6361557B1 (en) Staplebutton radiopaque marker
EP0901352B1 (en) Endoluminal prostheses having position indicating markers
EP1025811A2 (en) Endoluminal prosthesis having radiopaque marker
US20200330214A1 (en) Apparatus and methods for endoluminal graft placement
EP1684668B1 (en) Aorta and branch vessel stent grafts and system
EP1517651B1 (en) Thoracic aortic aneurysm stent graft
US6102938A (en) Endoluminal prosthetic bifurcation shunt
JP4746493B2 (en) System for occluding body lumens
JP4694575B2 (en) Bifurcated vascular graft design and deployment method
EP2227184B1 (en) Magnetic apparatus for in situ location of a graft fenestration site
JP2012501205A (en) Stent graft fixation coupling
EP2702960B1 (en) Endoluminal prosthesis and delivery device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP